Related Experiment Video
Updated: Jun 20, 2026
10:03
Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension
Published on: June 27, 2025
Is left ventricular hypertrophy regression important? Does the tool used to detect it matter?
Wadih Nadour1, Robert W W Biederman
1Division of Internal Medicine and Cardiology, Allegheny General Hospital, Pittsburgh, PA 15212, USA.
Journal of Clinical Hypertension (Greenwich, Conn.)
|August 22, 2009
Summary
Left ventricular hypertrophy (LVH) impacts cardiovascular prognosis. Cardiovascular magnetic resonance imaging (CMR) offers an accurate, noninvasive method to assess LVH and guide treatment goals for improved outcomes.
Area of Science:
- Cardiology
- Medical Imaging
- Cardiovascular Disease
Background:
- Left ventricular hypertrophy (LVH) is linked to adverse cardiovascular prognosis.
- Current noninvasive tools for LVH assessment are limited, hindering timely therapy initiation and regression monitoring.
- Accurate LVH quantification is crucial for effective cardiovascular risk management.
Purpose of the Study:
- To review current imaging modalities for assessing LVH and its regression.
- To highlight cardiovascular magnetic resonance imaging (CMR) as the gold standard for LVH evaluation.
- To establish a quantitative goal for left ventricular mass reduction following antihypertensive therapy.
Main Methods:
- Comprehensive review of existing literature on LVH imaging techniques.
- Focus on cardiovascular magnetic resonance imaging (CMR) for its accuracy, reproducibility, and cost-effectiveness.
- Analysis of Framingham data to inform target LV mass reduction goals.
Main Results:
- Cardiovascular magnetic resonance imaging (CMR) demonstrates ease, efficiency, and accuracy in delineating LVH.
- CMR is presented as a superior noninvasive tool compared to existing methods for LVH assessment.
- A novel goal for left ventricular mass reduction in grams is proposed for echocardiography and CMR.
Conclusions:
- Cardiovascular magnetic resonance imaging (CMR) is a reliable and accessible tool for evaluating left ventricular hypertrophy (LVH).
- Regression of LVH is important for improving cardiovascular outcomes.
- The proposed quantitative reduction goal aims to optimize antihypertensive therapy and reduce cardiovascular risk.
Related Concept Videos
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
01:22Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
01:29Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
01:20Mitral Regurgitation I: Introduction
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
01:23Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
01:25Aortic Regurgitation III: Medical Management
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...